Cue receives the first FDA EUA for home use without a prescription
Read Press Release
Molecular testing at the speed of life
An Official Point of Care Test of the NBA
Get the details
On the frontline of tackling COVID-19
Cue's COVID-19 test
Helping you get back to business
How Cue helpsWhat is Cue?
Cue is a connected, molecular diagnostic system
The Cue Health Monitoring System is a fast, compact, highly portable testing platform with no compromise in performance or accuracy. It uses molecular diagnostic technology to deliver reliable results in about 20 minutes.
Who we work with
Cue is partnering with leading organizations such as BARDA, Henry Schein, Johnson & Johnson, Mayo Clinic, and the National Basketball Association to further our science and protect human health.
Pressroom
View all pressCue Health Announces Completion of $235 Million Private Financing to Accelerate Growth
Cue Health Launches “Cue for Schools,” an On-Site Molecular Testing Solution for K-12 and Universities
Cue Health Expands Leadership Team with Key Executive Appointments
Cue Health Named One of Fierce Medtech’s “Fierce 15” Companies of 2020
FDA Authorizes Cue Health’s COVID-19 Test for At-Home and Over The Counter Use
Cue Receives CE Mark for Its Molecular Point-of-Care COVID-19 Test
Applications
One system, any industry
Accessible, accurate, scalable diagnostic testing for any industry, including healthcare, government, and education.
Who we are
Meet the team at Cue
We’re on a mission to transform how we detect disease and protect human health.
Made in the USA
Designed, engineered, manufactured, and tested in San Diego
Proudly headquartered in San Diego, Cue’s state-of-the-art space includes lab, office, and production facilities.
